GSK’s Potential Blockbuster Asthma Drug Gets European Backing
Europe’s drug regulator backed GSK Plc’s drug to treat severe asthma or a common nasal condition, in the first such…
Tag: GSKs
GSK’s $500 Million Booster
Get briefed ahead of your morning calls with the latest UK business headlines, key data and market reaction www.bloomberg.com #GSKs…